PRESS RELEASE published on 11/06/2025 at 22:15, 7 months 16 days ago Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 Revelation Biosciences, Inc. reports financial results for Q3 2025 and highlights milestone achievements in clinical study and fundraising, focusing on rebalancing inflammation for health optimization Financial Results Clinical Study Inflammation Revelation Biosciences Health Optimization
PRESS RELEASE published on 11/06/2025 at 22:05, 7 months 16 days ago Innodata Announces New Leadership Appointments to Support Next Phase of Growth Innodata Inc. announces executive management & Board appointments to support rapid growth in generative AI solutions. Rahul Singhal appointed President & CRO, Daniel Callahan & Richard Clarke to Board, Jack Abuhoff as Chairman, Stewart Massey as Lead Independent Director. Third Quarter 2025 results released Executive Management Innodata Inc. Board Appointments Generative AI Solutions Third Quarter 2025 Results
PRESS RELEASE published on 11/06/2025 at 22:05, 7 months 16 days ago ShelfieTech Ltd. Announces Private Placement of up to $2 Million ShelfieTech Ltd. announces a non-brokered private placement of up to $2 million for corporate purposes, R&D, acquisitions, and working capital. The Offering is subject to regulatory approvals Private Placement Common Shares Non-brokered Technological Solutions ShelfieTech Ltd.
PRESS RELEASE published on 11/06/2025 at 22:05, 7 months 16 days ago Unusual Machines Issues Letter to Shareholders Unusual Machines, Inc. CEO Allan Evans shares Q3 2025 highlights and strategic insights in a letter to shareholders. The company reported record revenue, profitability, and strong cash position for continued growth Record Revenue Strategic Insights Unusual Machines Inc. Q3 2025 Allan Evans
PRESS RELEASE published on 11/06/2025 at 22:05, 7 months 16 days ago Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update Protagonist Therapeutics reports financial results and updates on NDA submissions for icotrokinra and rusfertide, as well as progress in clinical trials for PN-881 and IND-enabling studies for PN-477sc and PN-477o Financial Results Clinical Trials Protagonist Therapeutics IND-enabling Studies NDA Submissions
REGULATED PRESS RELEASE published on 11/06/2025 at 22:00, 7 months 16 days ago Merger by absorption of the French company Interparfums Holding SAS by the French company Interparfums SA French company Interparfums SA plans merger by absorption with Interparfums Holding SAS. AMF decides no public offer needed, General Meeting on December 17, 2025, details available online Shareholders Merger AMF Interparfums General Meeting
PRESS RELEASE published on 11/06/2025 at 19:55, 7 months 16 days ago EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for financial year 2025 Pentixapharm Holding AG significantly reduces projected loss for financial year 2025 due to clinical development program realignment Clinical Development Realignment Pentixapharm Financial Year 2025 Projected Loss
PRESS RELEASE published on 11/06/2025 at 19:05, 7 months 16 days ago Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement Cell Impact and thyssenkrupp Automation Engineering enter Strategic Cooperation Agreement for Joint Market Success in Hydrogen field, focusing on flow plates and manufacturing processes for fuel cells and electrolyzers Fuel Cells Hydrogen Thyssenkrupp Cell Impact Strategic Cooperation Agreement
PRESS RELEASE published on 11/06/2025 at 18:51, 7 months 16 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 3,220 'A' Ordinary Shares at an average price of 616.00 GBp per share as part of share buyback programme Share Buyback Programme Numis Securities Limited Fuller Smith Turner PLC Own Shares Transaction
REGULATED PRESS RELEASE published on 11/06/2025 at 18:50, 7 months 16 days ago Total number of voting rights and shares making up the share capital at October 31, 2025 Compagnie de Saint-Gobain reports total number of voting rights and shares according to French Commercial Code and AMF General Regulations Share Capital Voting Rights French Commercial Code Compagnie De Saint-Gobain AMF General Regulations
Published on 06/23/2026 at 09:05, 47 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 06:45, 3 hours 7 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:01, 3 hours 51 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 7 hours 57 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 10 hours 27 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/23/2026 at 09:00, 51 minutes ago Hong Kong unlocks new opportunities with Central Asia
Published on 06/23/2026 at 08:55, 56 minutes ago JMGO Unveils Prime Day Savings of Up to 50% Across Its Triple-Laser Projector Lineup from June 23 to July 3
Published on 06/22/2026 at 18:00, 15 hours 52 minutes ago GUILLEMOT CORPORATION: STATEMENT REGARDING THE PASSING OF Mr. CLAUDE GUILLEMOT, CHAIRMAN OF GUILLEMOT CORPORATION GROUP
Published on 06/22/2026 at 08:30, 1 day 1 hour ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany